AGGRASTAT: Diabetes

Commited to bringing out the best in medicine

Healthcare Professionals

About AGGRASTAT^®

	Indications and Usage
	Dosing and Administration
	Efficacy
	Safety and Tolerability Profile

Key AGGRASTAT Studies

	PRISM
	PRISM-PLUS
	TACTICS
	A to Z Trial
	ACUTE II
	TIMI Criteria

High-Risk Patients

	ST-Segment Changes
	Renal Insufficiency
	Diabetes
	Elevated Troponin-I

Resources

Prescribing Information



					Email Me Updates
					Request More Information

High-Risk Patients

Diabetes

See Key AGGRASTAT Studies section.


	View References	Print

AGGRASTAT is a registered trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA

DISCLAIMER

Privacy Policy

Terms of Use

Copyright

Merck & CO., Inc. (USA)